ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial

Rohit Loomba, Stanley Wang, Dimple Desai, Daniel Santillano, Kathryn Jean Lucas, Guy Neff, Antonio C Bianco, Eveline Bruinstroop, Yan Su, Hardean E Achneck, Kha Le, Megan Fitzgerald, Min Wu, Tse-I Lin, Sushmita M Chanda, Lawrence M Blatt, Christos S Mantzoros

Open source

DOI: 10.1016/s2468-1253(26)00154-8
Published: 2026-08
Container: The Lancet Gastroenterology & Hepatology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-26-00154-8,
  title = {ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial},
  author = {Rohit Loomba and Stanley Wang and Dimple Desai and Daniel Santillano and Kathryn Jean Lucas and Guy Neff and Antonio C Bianco and Eveline Bruinstroop and Yan Su and Hardean E Achneck and Kha Le and Megan Fitzgerald and Min Wu and Tse-I Lin and Sushmita M Chanda and Lawrence M Blatt and Christos S Mantzoros},
  year = {2026},
  journal = {The Lancet Gastroenterology \&amp; Hepatology},
  doi = {10.1016/s2468-1253(26)00154-8},
  url = {https://doi.org/10.1016/s2468-1253(26)00154-8}
}

RIS

TY  - JOUR
TI  - ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial
AU  - Rohit Loomba
AU  - Stanley Wang
AU  - Dimple Desai
AU  - Daniel Santillano
AU  - Kathryn Jean Lucas
AU  - Guy Neff
AU  - Antonio C Bianco
AU  - Eveline Bruinstroop
AU  - Yan Su
AU  - Hardean E Achneck
AU  - Kha Le
AU  - Megan Fitzgerald
AU  - Min Wu
AU  - Tse-I Lin
AU  - Sushmita M Chanda
AU  - Lawrence M Blatt
AU  - Christos S Mantzoros
PY  - 2026
JO  - The Lancet Gastroenterology &amp; Hepatology
DO  - 10.1016/s2468-1253(26)00154-8
UR  - https://doi.org/10.1016/s2468-1253(26)00154-8
ER  -

APA

Loomba, R., Wang, S., Desai, D., Santillano, D., Lucas, K. J., Neff, G., Bianco, A. C., Bruinstroop, E., Su, Y., Achneck, H. E., Le, K., Fitzgerald, M., Wu, M., Lin, T., Chanda, S. M., Blatt, L. M., & Mantzoros, C. S. (2026). ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(26)00154-8

Source records

crossref · retrieved 2026-09-26T18:05:28.470Z